comparemela.com

Latest Breaking News On - ஒரேன் லிவ்னாட் - Page 2 : comparemela.com

MannKind Corporation (MNKD) Q1 2021 Earnings Call Transcript

Operator Good afternoon, and welcome to MannKind Corporation first-quarter 2021 earnings call. As a reminder this call is being recorded on May 12th, 2021, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until May 26, 2021. This call will contain forward-looking statements. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from these stated expectations. For further information on the company s risk factors please see their 10-Q report filed with the Securities and Exchange Commission this morning, the earnings release and the slides prepared for this presentation. Joining us today from Mannkind are Chief Executive Officer Michael Castagna, and Chief Financial Officer Steven Binder. I would now like to turn the conference over to Mr. Castagna.

Cara Therapeutics Inc (CARA) Q1 2021 Earnings Call Transcript

Operator I would now like to turn the call over to the CARA team. Please proceed. Jack Hildick-Smith Investor Relations Good afternoon, this is Jack Hildick-Smith with Stern Investor Relations and welcome to Cara Therapeutics first quarter 2021 financial results and update conference call. The news release became available just after 4:00 PM today and can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today s call on the Investors section of the website. Before we begin, let me remind you that statements made on today s call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements, include statements concerning the expected timing of the data readouts from the company s planned and ongoing clinical trials, the potential results of ongoing clinical trials, timing of future regul

Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript

Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Avadel Pharmaceuticals plc (NASDAQ: AVDL) Q1 2021 Earnings Call Operator Greetings, and welcome to the Avadel Pharmaceuticals First Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Tom McHugh, Chief Financial Officer. Thank you. You may begin.SPONSORED: 10 stocks we like better than Avadel Pharmaceuticals plc When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

Agile Therapeutics (AGRX) Q1 2021 Earnings Call Transcript

Operator Good afternoon and welcome to the Agile Therapeutics first-quarter 2021 financial results conference call. Please note today s event is being recorded. I would like to turn the conference over to Matt Riley, head of investor relations. Matt Riley Head of Investor Relations Hello, everyone, and welcome to today s conference call to discuss our first-quarter 2021 financial results and corporate update. Before we start, let me remind you that today s call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, management s expectations for our future financial and operational performance, our business strategy, our assessment of the combined hormonal contraceptive market, and the potential market share for Twirla, among other statements regarding our plans prospects and expectations. Such statements represent our judgment as of today, are not promises or guarantees, and may involve risks

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.